SIM
OSIR

Sonora Investment Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Sonora Investment Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-200
Closed -$992 – 884
2016
Q3 		$992 Sell
200
-500
-71% -$2.56K ﹤0.01% 783
2016
Q2 		$3.56K Hold
700
– – ﹤0.01% 731
2016
Q1 		$4.3K Hold
700
– – ﹤0.01% 754
2015
Q4 		$7K Hold
700
– – ﹤0.01% 604
2015
Q3 		$13K Buy
+700
New +$13.5K ﹤0.01% 425

Other funds holding OSIR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sonora Investment Management's OSIR Position: Q4 2016 in Review

Sonora Investment Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2016, closing a stake of 200 shares — an estimated $992 sold.

Sonora Investment Management first reported a position in OSIR in Q3 2015 and held it in 5 quarters. The position peaked at $13K in Q3 2015. 64 funds tracked by Wall St. Rank hold OSIR as of Q4 2016.

  • Sonora Investment Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Sonora Investment Management sold 200 Osiris Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $992.
  • Sonora Investment Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2015 and held it in 5 quarters.
  • Sonora Investment Management's Osiris Therapeutics, Inc. Common Stock position peaked at $13K in Q3 2015.
  • 64 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Sonora Investment Management's 13F filing for Q4 2016, filed 12 Jan 2017.